KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Shares Issued (2017 - 2022)

Fulgent Genetics (FLGT) has disclosed Shares Issued for 6 consecutive years, with $12000.0 as the latest value for Q4 2022.

  • Quarterly Shares Issued rose 100.02% to $12000.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $12000.0 through Dec 2023, down 61.29% year-over-year, with the annual reading at $1000.0 for FY2025, 98.04% down from the prior year.
  • Shares Issued hit $12000.0 in Q4 2022 for Fulgent Genetics, up from $3000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $246.1 million in Q4 2020 to a low of -$75.5 million in Q4 2021.
  • Historically, Shares Issued has averaged $13.0 million across 5 years, with a median of $7000.0 in 2018.
  • Biggest YoY gain for Shares Issued was 2050633.33% in 2020; the steepest drop was 4680.0% in 2020.
  • Year by year, Shares Issued stood at $5000.0 in 2018, then skyrocketed by 140.0% to $12000.0 in 2019, then soared by 2050633.33% to $246.1 million in 2020, then plummeted by 130.7% to -$75.5 million in 2021, then surged by 100.02% to $12000.0 in 2022.
  • Business Quant data shows Shares Issued for FLGT at $12000.0 in Q4 2022, $3000.0 in Q2 2022, and $16000.0 in Q1 2022.